Masimo Corp. has received Food and Drug Administration marketing approval for its Pronto-7. The handheld device offers convenient, non-invasive spot check testing of hemoglobin. The product can also ...
Nov 15 (Reuters) - Masimo Corp , a maker of non-invasive patient monitoring products, told U.S. regulators that it received allegations about the safety and efficacy of its hemoglobin testing products ...
Masimo‘s Pronto, showcased at the recent National Association of Directors of Nursing Administration in Long-Term Care conference, is a portable, handheld Pulse CO-Oximeter that offers noninvasive and ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto ® Pulse CO-Oximeter ® with Next Generation SpHb ® Spot Check ...
NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that updated guidelines published by the European Society of Anaesthesiology and Intensive Care (ESAIC) highlight the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results